Sintx Technologies (SINT) Net Income towards Common Stockholders Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 64.73% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.89% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 29.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 14.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.04% |
| Dec 31, 2025 | 41.40% |
| Sep 30, 2025 | -55.58% |
| Jun 30, 2025 | 4.00% |
| Mar 31, 2025 | 6.90% |
| Dec 31, 2024 | 15.71% |
| Sep 30, 2024 | -38.61% |
| Jun 30, 2024 | -4.59% |
| Mar 31, 2024 | -12.33% |
| Dec 31, 2023 | -50.07% |
| Sep 30, 2023 | -12.18% |
| Jun 30, 2023 | 5.08% |
| Mar 31, 2023 | -14.02% |
| Dec 31, 2022 | -90.79% |
| Sep 30, 2022 | -12.07% |
| Jun 30, 2022 | 11.03% |
| Mar 31, 2022 | -20.43% |
| Dec 31, 2021 | -38.95% |
| Sep 30, 2021 | 45.00% |
| Jun 30, 2021 | -0.27% |
| Mar 31, 2021 | 10.89% |
| Dec 31, 2020 | 9.02% |
| Sep 30, 2020 | -6.68% |
| Jun 30, 2020 | -33.24% |
| Mar 31, 2020 | -80.22% |
| Dec 31, 2019 | -12.14% |
| Sep 30, 2019 | 44.74% |
| Jun 30, 2019 | 9.77% |
| Mar 31, 2019 | 21.66% |
| Dec 31, 2018 | 24.64% |
| Sep 30, 2018 | -11.60% |
| Jun 30, 2018 | 28.36% |
| Mar 31, 2018 | 11.57% |
| Dec 31, 2017 | 34.64% |
| Sep 30, 2017 | 25.14% |
| Jun 30, 2017 | 49.52% |
| Mar 31, 2017 | 52.28% |
| Dec 31, 2016 | -54.64% |
| Sep 30, 2016 | -69.65% |
| Jun 30, 2016 | -18.21% |
| Mar 31, 2016 | 1.40% |